Tumor seeding during colonoscopy as a possible cause for metachronous colorectal cancer

Y Backes, TCJ Seerden, RSFE van Gestel… - Gastroenterology, 2019 - Elsevier
Background and Aims In patients who have undergone surgery for colorectal cancer (CRC),
3% have recurrence of (metachronous) CRC. We investigated whether tumor seeding …

Extracellular vesicles for drug delivery

P Vader, EA Mol, G Pasterkamp… - Advanced drug delivery …, 2016 - Elsevier
Extracellular vesicles (EVs) are cell-derived membrane vesicles, and represent an endogenous
mechanism for intercellular communication. Since the discovery that EVs are capable of …

Curcumin nanoformulations: a review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatment

O Naksuriya, S Okonogi, RM Schiffelers, WE Hennink - Biomaterials, 2014 - Elsevier
Curcumin, a natural yellow phenolic compound, is present in many kinds of herbs,
particularly in Curcuma longa Linn. (turmeric). It is a natural antioxidant and has shown many …

[HTML][HTML] Extracellular vesicles as drug delivery systems: Why and how?

OM Elsharkasy, JZ Nordin, DW Hagey… - Advanced drug delivery …, 2020 - Elsevier
Over the past decades, a multitude of synthetic drug delivery systems has been developed
and introduced to the market. However, applications of such systems are limited due to …

[HTML][HTML] Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation

H Kalra, RJ Simpson, H Ji, E Aikawa, P Altevogt… - PLoS …, 2012 - journals.plos.org
Extracellular vesicles (EVs) are membraneous vesicles released by a variety of cells into
their microenvironment. Recent studies have elucidated the role of EVs in intercellular …

Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle

RM Schiffelers, A Ansari, J Xu, Q Zhou… - Nucleic acids …, 2004 - academic.oup.com
Potent sequence selective gene inhibition by siRNA ‘targeted’ therapeutics promises the
ultimate level of specificity, but siRNA therapeutics is hindered by poor intracellular uptake, …

[PDF][PDF] In vivo imaging reveals extracellular vesicle-mediated phenocopying of metastatic behavior

A Zomer, C Maynard, FJ Verweij, A Kamermans… - Cell, 2015 - cell.com
Most cancer cells release heterogeneous populations of extracellular vesicles (EVs) containing
proteins, lipids, and nucleic acids. In vitro experiments showed that EV uptake can lead …

Obstacles and opportunities in the functional analysis of extracellular vesicle RNA–an ISEV position paper

B Mateescu, EJK Kowal, BWM van Balkom… - Journal of …, 2017 - Taylor & Francis
The release of RNA-containing extracellular vesicles (EV) into the extracellular milieu has
been demonstrated in a multitude of different in vitro cell systems and in a variety of body fluids…

Cellular stress conditions are reflected in the protein and RNA content of endothelial cell-derived exosomes

OG de Jong, MC Verhaar, Y Chen, P Vader… - Journal of …, 2012 - Taylor & Francis
Background: The healthy vascular endothelium, which forms the barrier between blood and
the surrounding tissues, is known to efficiently respond to stress signals like hypoxia and …

RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature

K Temming, RM Schiffelers, G Molema, RJ Kok - Drug resistance updates, 2005 - Elsevier
During the past decade, RGD-peptides have become a popular tool for the targeting of drugs
and imaging agents to α v β 3 -integrin expressing tumour vasculature. RGD-peptides have …